甲狀腺腫瘤生物分子標幟之研究

Abstract

In clinic, for follicular thyroid carcinoma there is no special examination tool or marker which can differentiate malignant from benign nodules. The other perturbation is that the patients of anaplastic carcinoma usually die within months of diagnosis, regardless of therapy. Aims：In principle, genetic changes can be identified by screening at various levels：cellular phenotypes, DNA, RNA and protein. This study is to identify the differentially expressed proteins or genes in thyroid cancer cells versus th